샘플 요청 목록

 카트 문의
시장보고서
상품코드
2151535

랜싱 디바이스 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 최종 용도별, 용도별, 유통 채널별, 지역별 및 부문별 예측(2026-2033년)

Lancing Device Market Size, Share & Trends Analysis Report By Product, By End-use, By Application, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033
발행일: | 리서치사: 구분자 Grand View Research | 페이지 정보: 영문 130 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




가격
Unprintable PDF & Excel (Single User License) help
보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.
US $ 5,950 금액 안내 화살표 ￦ 7,968,000
Printable PDF & Excel (5-User License) help
보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.
US $ 6,950 금액 안내 화살표 ￦ 9,308,000
Printable PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.
US $ 8,950 금액 안내 화살표 ￦ 11,986,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

천자 장치 시장 요약

세계의 랜싱 디바이스 시장 규모는 2025년에 35억 달러로 평가되며, 2026년 37억 달러에서 2033년까지 66억 달러로 확대하며, 2026-2033년까지 연평균 성장률(CAGR)은 8.5%에 달할 것으로 예측됩니다.

북미가 시장을 주도하고 있으며, 2025년에는 매출 점유율의 42.5%를 차지했습니다. 시장 성장은 당뇨병 유병률 증가, 자가혈당측정(SMBG)의 보급 확대, 가정내 당뇨병 관리의 확대, 그리고 편의성이 높은 모세혈관 채혈에 대한 지속적인 수요에 의해 견인되고 있습니다.

또한 재택 간호 및 의료 현장에서 통증이 적고, 천자 깊이를 조절할 수 있으며, 인체공학에 기반을 두고 안전성을 고려하여 설계된 천자 기기의 사용이 증가하고 있는 점도 시장 성장을 지원하고 있습니다. 전 세계 당뇨병 부담이 증가함에 따라 정기적인 혈당 모니터링이 필요한 환자 수가 늘어나고 있으며, 이는 천자 기기 업계의 수요를 지원할 것으로 예상됩니다. 국제당뇨병연맹(IDF)의 '당뇨병 아틀라스' 제11판(2025년)에 따르면 당뇨병을 앓고 있는 성인 수는 2024년 5억 8,870만 명에서 2050년까지 8억 5,250만 명으로 증가할 것으로 예측되며,이로 인해 모세혈관 채혈 및 자가혈당측정 제품에 대한 수요가 높아질 것으로 전망됩니다. 아프리카에서는 142%의 증가가 예상되며, 당뇨병 관리 인프라 확충과 모니터링 기술에 대한 접근성 향상으로 인해 큰 성장 기회가 기대되고 있습니다.

중동·북아프리카(MENA) 지역 및 동남아시아는 각각 92% 및 73%의 성장이 예상되며, 합리적인 가격에 사용하기 편리한 채혈 기기의 수요를 견인할 것으로 전망됩니다. 한편, 서태평양 지역은 당뇨병 환자 수가 많기 때문에 계속해서 주요 시장으로 자리매김할 것입니다. 전반적으로 당뇨병 유병률의 상승, 자가 관리의 확대, 그리고 의료 서비스 접근성 증대가 전 세계 채혈 기기의 보급을 지원할 것입니다.

자주 묻는 질문

  • 천자 장치 시장의 규모는 어떻게 변할 것으로 예상되나요?
  • 북미 지역의 랜싱 디바이스 시장 점유율은 어떻게 되나요?
  • 당뇨병 유병률 증가가 랜싱 디바이스 시장에 미치는 영향은 무엇인가요?
  • 아프리카 지역의 당뇨병 관리 시장 성장률은 어떻게 되나요?
  • 동남아시아 지역의 랜싱 디바이스 시장 성장률은 어떻게 되나요?
  • 천자 장치 시장의 주요 기업은 어디인가요?

목차

제1장 조사 방법과 범위

제2장 개요

제3장 랜싱 디바이스 시장 : 변수, 동향, 범위

  • 시장 계보 전망
  • 시장 역학
  • 랜싱 디바이스 시장 분석 툴

제4장 랜싱 디바이스 시장 : 제품별 추정·동향 분석

  • 세계의 랜싱 디바이스 시장 : 제품별 동향 분석, 2025년 & 2033년
  • 세계의 랜싱 디바이스 시장 : 제품별 규모·동향 분석, 2021-2033년
  • 재사용 가능한 깊이 조절형 채혈 펜
  • 재사용 가능한 고정 깊이 채혈 펜
  • 일회용 안전 채혈 디바이스

제5장 랜싱 디바이스 시장 : 최종 용도별 추정·동향 분석

  • 세계의 랜싱 디바이스 시장 : 최종 용도별 동향 분석, 2025년 & 2033년
  • 세계의 랜싱 디바이스 시장 : 최종 용도별 규모·동향 분석, 2021-2033년
  • 홈케어 용도
  • 병원
  • 임상/진단 검사실
  • 진료소
  • 장기 케어 시설

제6장 랜싱 디바이스 시장 : 용도별 추정·동향 분석

  • 세계의 랜싱 디바이스 시장 : 용도별 동향 분석, 2025년 & 2033년
  • 세계의 랜싱 디바이스 시장 : 용도별 규모·동향 분석, 2021-2033년
  • 혈당 측정
  • 콜레스테롤/지질 패널 검사
  • 헤모글로빈/빈혈 스크리닝
  • 응고 검사
  • 심장 효소/POC(Point-Of-Care) 진단 검사
  • 신생아 스크리닝

제7장 랜싱 디바이스 시장 : 유통 채널별 추정·동향 분석

  • 세계의 랜싱 디바이스 시장 : 유통 채널별 동향 분석, 2025년 & 2033년
  • 세계의 랜싱 디바이스 시장 : 유통 채널별 규모·동향 분석, 2021-2033년
  • 소매 채널
    • 소매 약국/OTC
    • E-Commerce/DTC
  • 기관용 채널
    • 병원
    • 진단 체인 및 임상 검사실 조달

제8장 랜싱 디바이스 시장 : 지역별 추정·동향 분석

  • 지역별 대시보드
  • 시장 규모·동향 분석, 2021-2033년
  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 이탈리아
    • 스페인
    • 스웨덴
    • 덴마크
    • 노르웨이
  • 아시아태평양
    • 중국
    • 일본
    • 인도
    • 한국
    • 호주
    • 태국
  • 라틴아메리카
    • 브라질
    • 아르헨티나
  • 중동 및 아프리카
    • 남아프리카공화국
    • 사우디아라비아
    • UAE
    • 쿠웨이트

제9장 경쟁 구도

  • 주요 시장 참여 기업별 최근 동향과 영향 분석
  • 기업 분류
  • 기업 점유율 분석, 2025년
  • 기업 히트맵 분석
  • 전략 지도제작
    • 사업 확대
    • 합병·인수
    • 제휴·협업
    • 신기술의 투입
    • 연구개발
    • 기업 개요
    • Roche Diabetes Care (Roche Holding AG)
    • Lifescan Enterprises LLC.(Platinum Equity)
    • Ascensia Diabetes Care Holdings AG (PHC Holdings)
    • Trividia Health, Inc.(Sinocare Group)
    • Owen Mumford (Embecta Corp.)
    • BD
    • Bionime Corporation
    • Abbott Laboratories
    • B. Braun SE
    • Greiner Bio-One International GmbH
    • Terumo Corporation
    • SARSTEDT AG &Co. KG
    • HTL Strefa
    • i-SENS, Inc.
    • Letsgetchecked
KSA 26.10.22

Lancing Device Market Summary

The global lancing device market size was valued at USD 3.5 billion in 2025 and is projected to grow from USD 3.7 billion in 2026 to USD 6.6 billion by 2033, at a CAGR of 8.5% from 2026 to 2033. North America dominated the market, accounting for the revenue share of 42.5% in 2025. The market growth is driven by the increasing prevalence of diabetes, growing adoption of self-monitoring blood glucose (SMBG), expansion of home-based diabetes management, and continued demand for convenient capillary blood sampling.

The market is further supported by the increasing use of low-pain, adjustable-depth, ergonomic, and safety-engineered lancing devices across home-care and healthcare settings. The growing global diabetes burden is expected to support demand for the lancing device industry, as increasing numbers of patients require regular blood glucose monitoring. According to the International Diabetes Federation (IDF) Diabetes Atlas, 11th Edition (2025), the number of adults living with diabetes is projected to rise from 588.7 million in 2024 to 852.5 million by 2050, increasing the need for capillary blood sampling and self-monitoring blood glucose products. Africa, with a projected 142% increase, is expected to offer significant growth opportunities due to expanding diabetes-care infrastructure and increasing access to monitoring technologies.

MENA and South-East Asia, projected to grow by 92% and 73%, respectively, are also expected to drive demand for affordable and easy-to-use lancing devices. Meanwhile, the Western Pacific region will remain a major market because of its large diabetic population. Overall, rising diabetes prevalence, greater self-management, and expanding healthcare access will support the adoption of lancing devices globally.

Global Lancing Device Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global lancing device market report based on product, end-use, application, distribution channel, and region:

  • Product Outlook (Revenue, USD Billion, 2021 - 2033)
  • Reusable Adjustable-Depth Lancing Pens
  • Reusable Fixed-Depth Lancing Pens
  • Single-Use Safety Lancing Devices
  • End-use Outlook (Revenue, USD Billion, 2021 - 2033)
  • Home-care use
  • Hospital
  • Clinical / Diagnostic laboratories
  • Physician office
  • Long-term care facilities
  • Application Outlook (Revenue, USD Billion, 2021 - 2033)
  • Blood glucose monitoring
  • Cholesterol / Lipid Panel Testing
  • Hemoglobin / Anemia Screening
  • Coagulation Testing
  • Cardiac Enzyme / Point-of-Care Diagnostic Testing
  • Neonatal Screening
  • Distribution Channel Outlook (Revenue, USD Billion, 2021 - 2033)
  • Retail Channels
  • Retail Pharmacy/OTC
  • E-commerce/DTC
  • Institutional Channels
  • Hospital
  • Diagnostic chains & clinical labs procurement
  • Regional Outlook (Revenue, USD Billion, 2021-2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Thailand
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Product
    • 1.1.2. End-Use
    • 1.1.3. Application
    • 1.1.4. Distribution Channel
    • 1.1.5. Regional Scope
    • 1.1.6. Estimates and Forecast Timeline
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
  • 1.5. Details of Primary Research
    • 1.5.1. Data for Primary interviews in North America
    • 1.5.2. Data for Primary interviews in Europe
    • 1.5.3. Data for Primary interviews in Asia Pacific
    • 1.5.4. Data for Primary interviews in Latin America
    • 1.5.5. Data for Primary interviews in MEA
  • 1.6. Market formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis (Model 1)
      • 1.7.1.1. Approach 1: Commodity Flow Approach
    • 1.7.2. Volume Price Analysis (Model 2)
      • 1.7.2.1. Approach 2: Volume Price Analysis
  • 1.8. Research Scope and Assumptions
    • 1.8.1. List of Secondary Sources
    • 1.8.2. List of Primary Sources
    • 1.8.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive insights

Chapter 3. Lancing Device Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Rising Global Diabetes Prevalence
      • 3.2.1.2. Continued Need for Capillary Blood Glucose Monitoring
      • 3.2.1.3. Expansion of Diabetes Self-Management and Home Monitoring
      • 3.2.1.4. Growing Demand for Safe, Auto-Disinfecting Lancing Devices
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. Rapid Adoption of Continuous Glucose Monitoring (CGM)
      • 3.2.2.2. Infection-Control and Sharps-Safety Requirements
    • 3.2.3. Market Opportunity Analysis
      • 3.2.3.1. Development of Ultra-Low-Pain and Adjustable-Depth Lancing Devices
      • 3.2.3.2. Expansion of Single-Use Safety-Engineered Lancing Devices
      • 3.2.3.3. Increasing Glucose Monitoring During Pregnancy and Gestational Diabetes
      • 3.2.3.4. Demand for Affordable Lancing Devices in Emerging Markets
      • 3.2.3.5. Integration of Lancing Devices with Connected Diabetes-Management Platforms
    • 3.2.4. Market Challenge Analysis
      • 3.2.4.1. Increasing Competition from Continuous Glucose Monitoring Technologies
      • 3.2.4.2. Maintaining Infection-Control Compliance in Assisted Blood-Glucose Testing
  • 3.3. Lancing Device Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining Power of the Suppliers
      • 3.3.1.2. Bargaining Power of the Buyers
      • 3.3.1.3. Threats of Substitution
      • 3.3.1.4. Threats from New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological Landscape
      • 3.3.2.4. Environmental Landscape
      • 3.3.2.5. Legal Landscape

Chapter 4. Lancing Device Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Lancing Device Market: Product Movement Analysis, 2025 & 2033 (USD Billion)
  • 4.3. Global Lancing Device Market Size & Trend Analysis, By Product, 2021 To 2033 (USD Billion)
  • 4.4. Reusable Adjustable-Depth Lancing Pens
    • 4.4.1. Reusable Adjustable-Depth Lancing Pens Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.5. Reusable Fixed-Depth Lancing Pens
    • 4.5.1. Reusable Fixed-Depth Lancing Pens Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.6. Single-Use Safety Lancing Devices
    • 4.6.1. Single-Use Safety Lancing Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 5. Lancing Device Market: End-Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Lancing Device Market: End-Use Movement Analysis, 2025 & 2033 (USD Billion)
  • 5.3. Global Lancing Device Market Size & Trend Analysis, By End-Use, 2021 To 2033 (USD Billion)
  • 5.4. Home-Care Use
    • 5.4.1. Home-Care Use Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 5.5. Hospital
    • 5.5.1. Hospital Market Revenue Estimates and forecasts, 2021 - 2033 (USD Billion)
  • 5.6. Clinical / Diagnostic Laboratories
    • 5.6.1. Clinical / Diagnostic Laboratories Market Revenue Estimates and forecasts, 2021 - 2033 (USD Billion)
  • 5.7. Physician's office
    • 5.7.1. Physician office Market Revenue Estimates and forecasts, 2021 - 2033 (USD Billion)
  • 5.8. Long-Term Care Facilities
    • 5.8.1. Long-Term Care Facilities Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 6. Lancing Device Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Lancing Device Market: Application Movement Analysis, 2025 & 2033 (USD Billion)
  • 6.3. Global Lancing Device Market Size & Trend Analysis, By Application 2021 To 2033 (USD Billion)
  • 6.4. Blood Glucose Monitoring
    • 6.4.1. Blood Glucose Monitoring Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 6.5. Cholesterol / Lipid Panel Testing
    • 6.5.1. Cholesterol / Lipid Panel Testing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 6.6. Hemoglobin / Anemia Screening
    • 6.6.1. Hemoglobin / Anemia Screening Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 6.7. Coagulation Testing
    • 6.7.1. Coagulation Testing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 6.8. Cardiac Enzyme / Point-of-Care Diagnostic Testing
    • 6.8.1. Cardiac Enzyme / Point-of-Care Diagnostic Testing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 6.9. Neonatal Screening
    • 6.9.1. Neonatal Screening Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 7. Lancing Device Market: Distribution Channel Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Lancing Device Market: Distribution Channel Movement Analysis, 2025 & 2033 (USD Billion)
  • 7.3. Global Lancing Device Market Size & Trend Analysis, By Distribution Channel, 2021 To 2033 (USD Billion)
  • 7.4. Retail Channels
    • 7.4.1. Retail Channels Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.4.2. Retail Pharmacy/OTC
      • 7.4.2.1. Retail Pharmacy/OTC Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.4.3. E-Commerce/DTC
      • 7.4.3.1. E-Commerce/DTC Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.5. Institutional Channels
    • 7.5.1. Institutional Channels Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.5.2. Hospital
      • 7.5.2.1. Hospital Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.5.3. Diagnostic Chains & Clinical Labs Procurement
      • 7.5.3.1. Diagnostic Chains & Clinical Labs Procurement Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 8. Lancing Device Market: Regional Estimates & Trend Analysis By Product, End-Use, Application, and Distribution Channel

  • 8.1. Regional Dashboard
  • 8.2. Market Size and Trend Analysis, 2021 To 2033
  • 8.3. North America
    • 8.3.1. North America Lancing Device Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.3.2. U.S.
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. Reimbursement Scenario
      • 8.3.2.5. U.S. Lancing Device Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Reimbursement Scenario
      • 8.3.3.5. Canada Lancing Device Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.3.4. Mexico
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Reimbursement Scenario
      • 8.3.4.5. Mexico Lancing Device Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.4. Europe
    • 8.4.1. Europe Lancing Device Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.4.2. UK
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Reimbursement Scenario
      • 8.4.2.5. UK Lancing Device Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.4.3. Germany
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Reimbursement Scenario
      • 8.4.3.5. Germany Lancing Device Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.4.4. France
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Reimbursement Scenario
      • 8.4.4.5. France Lancing Device Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.4.5. Italy
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Reimbursement Scenario
      • 8.4.5.5. Italy Lancing Device Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.4.6. Spain
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Reimbursement Scenario
      • 8.4.6.5. Spain Lancing Device Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.4.7. Sweden
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Reimbursement Scenario
      • 8.4.7.5. Sweden Lancing Device Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.4.8. Denmark
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Competitive Scenario
      • 8.4.8.3. Regulatory Framework
      • 8.4.8.4. Reimbursement Scenario
      • 8.4.8.5. Denmark Lancing Device Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.4.9. Norway
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Competitive Scenario
      • 8.4.9.3. Regulatory Framework
      • 8.4.9.4. Reimbursement Scenario
      • 8.4.9.5. Norway Lancing Device Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific Lancing Device Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.5.2. China
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Reimbursement Scenario
      • 8.5.2.5. China Lancing Device Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.5.3. Japan
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Reimbursement Scenario
      • 8.5.3.5. Japan Lancing Device Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.5.4. India
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. Reimbursement Scenario
      • 8.5.4.5. India Lancing Device Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.5.5. South Korea
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Reimbursement Scenario
      • 8.5.5.5. South Korea Lancing Device Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.5.6. Australia
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Reimbursement Scenario
      • 8.5.6.5. Australia Lancing Device Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.5.7. Thailand
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. Reimbursement Scenario
      • 8.5.7.5. Thailand Lancing Device Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.6. Latin America
    • 8.6.1. Latin America Lancing Device Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.6.2. Brazil
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Reimbursement Scenario
      • 8.6.2.5. Brazil Lancing Device Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.6.3. Argentina
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Reimbursement Scenario
      • 8.6.3.5. Argentina Lancing Device Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.7. Middle East and Africa
    • 8.7.1. Middle East and Africa Lancing Device Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.7.2. South Africa
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. Reimbursement Scenario
      • 8.7.2.5. South Africa Lancing Device Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.7.3. Saudi Arabia
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Reimbursement Scenario
      • 8.7.3.5. Saudi Arabia Lancing Device Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.7.4. UAE
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Framework
      • 8.7.4.4. Reimbursement Scenario
      • 8.7.4.5. UAE Lancing Device Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory Framework
      • 8.7.5.4. Reimbursement Scenario
      • 8.7.5.5. Kuwait Lancing Device Market Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Market Share Analysis, 2025
  • 9.4. Company Heat Map Analysis
  • 9.5. Strategy Mapping
    • 9.5.1. Expansion
    • 9.5.2. Mergers & Acquisition
    • 9.5.3. Partnerships & Collaborations
    • 9.5.4. New Technology Launches
    • 9.5.5. Research and Development
    • 9.5.6. Company Profiles
    • 9.5.7. Roche Diabetes Care (Roche Holding AG)
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Financial Performance
      • 9.5.7.3. Product Benchmarking
      • 9.5.7.4. Strategic initiatives
    • 9.5.8. Lifescan Enterprises LLC. (Platinum Equity)
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Financial Performance
      • 9.5.8.3. Product Benchmarking
      • 9.5.8.4. Strategic initiatives
    • 9.5.9. Ascensia Diabetes Care Holdings AG (PHC Holdings)
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Financial Performance
      • 9.5.9.3. Product Benchmarking
      • 9.5.9.4. Strategic initiatives
    • 9.5.10. Trividia Health, Inc. (Sinocare Group)
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Financial Performance
      • 9.5.10.3. Product Benchmarking
      • 9.5.10.4. Strategic initiatives
    • 9.5.11. Owen Mumford (Embecta Corp.)
      • 9.5.11.1. Company Overview
      • 9.5.11.2. Financial Performance
      • 9.5.11.3. Product Benchmarking
      • 9.5.11.4. Strategic initiatives
    • 9.5.12. BD
      • 9.5.12.1. Company Overview
      • 9.5.12.2. Financial Performance
      • 9.5.12.3. Product Benchmarking
      • 9.5.12.4. Strategic initiatives
    • 9.5.13. Bionime Corporation
      • 9.5.13.1. Company Overview
      • 9.5.13.2. Financial Performance
      • 9.5.13.3. Product Benchmarking
      • 9.5.13.4. Strategic initiatives
    • 9.5.14. Abbott Laboratories
      • 9.5.14.1. Company Overview
      • 9.5.14.2. Financial Performance
      • 9.5.14.3. Product Benchmarking
      • 9.5.14.4. Strategic initiatives
    • 9.5.15. B. Braun SE
      • 9.5.15.1. Company Overview
      • 9.5.15.2. Financial Performance
      • 9.5.15.3. Product Benchmarking
      • 9.5.15.4. Strategic initiatives
    • 9.5.16. Greiner Bio-One International Gmbh
      • 9.5.16.1. Company Overview
      • 9.5.16.2. Financial Performance
      • 9.5.16.3. Product Benchmarking
      • 9.5.16.4. Strategic initiatives
    • 9.5.17. Terumo Corporation
      • 9.5.17.1. Company Overview
      • 9.5.17.2. Financial Performance
      • 9.5.17.3. Product Benchmarking
      • 9.5.17.4. Strategic initiatives
    • 9.5.18. SARSTEDT AG & Co. KG
      • 9.5.18.1. Company Overview
      • 9.5.18.2. Financial Performance
      • 9.5.18.3. Product Benchmarking
      • 9.5.18.4. Strategic initiatives
    • 9.5.19. HTL Strefa
      • 9.5.19.1. Company Overview
      • 9.5.19.2. Financial Performance
      • 9.5.19.3. Product Benchmarking
      • 9.5.19.4. Strategic initiatives
    • 9.5.20. i-SENS, Inc.
      • 9.5.20.1. Company Overview
      • 9.5.20.2. Financial Performance
      • 9.5.20.3. Product Benchmarking
      • 9.5.20.4. Strategic initiatives
    • 9.5.21. Letsgetchecked
      • 9.5.21.1. Company Overview
      • 9.5.21.2. Financial Performance
      • 9.5.21.3. Product Benchmarking
      • 9.5.21.4. Strategic initiatives
×

원하시는 정보를 찾아 드릴까요?

보안문자 새로고침
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
email
문의하기